UNSPSC 51101917: Amquinate

This classification denotes an antiprotozoal agent with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21N28Z70CI, chemically known as 3-quinolinecarboxylic acid, 7-(diethylamino)-4-hydroxy-6-propyl-, methyl ester but generally known as amquinate, which bears US NIH Compound Identifier 28414. European Medicines Agency schedules Amquinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05492MIG.

UNSPSC 51101917 Amquinate is a Commodity code that in recent state and local procurement activity covers the supply of pharmaceutical products used in emergency response and community health initiatives, including opioid-antagonist medications and drug disposal systems. The code sees application across state health departments and county public health agencies, which acquire these pharmaceuticals through piggyback contracts, competitive bidding processes, and cooperative purchasing consortia to support emergency preparedness, overdose response, and controlled-substance management programs.

Recent activity spans Illinois and Florida, with the Illinois Department of Public Health awarding a $2.99 million piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for the supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, and Seminole County, Florida issuing a competitive bid in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Both procurements required vendor compliance with federal and local regulatory requirements, including drug-free workplace certification and E-Verify compliance, with the Seminole County contract carrying a probationary termination clause and potential FEMA funding implications.